Centene Management

Management criteria checks 1/4

Centene's El consejero delegado es Sarah London , nombrado en Mar 2022, tiene un mandato de 1.75 años. la remuneración anual total es $13.25M , compuesta por 10.3% salario y 89.7% primas, incluidas acciones y opciones de la empresa. posee directamente 0.1% de las acciones de la empresa, por valor de MX$711.20M . La antigüedad media del equipo directivo y del consejo de administración es de 2.6 años y 2.1 años respectivamente.

Key information

Sarah London

Chief executive officer

US$18.6m

Total compensation

CEO salary percentage	7.5%
CEO tenure	2.1yrs
CEO ownership	0.02%
Management average tenure	2.5yrs
Board average tenure	2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sarah London's remuneration changed compared to Centene's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$19m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$1b
Dec 31 2022	US$13m	US$1m	US$1b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	US$15m	US$978k	US$1b

Compensación vs. Mercado: Sarah($USD13.25M) está por encima de la media de empresas de tamaño similar en el mercado MX ($USD5.70M).

Compensación vs. Ingresos: Sarahha aumentado más de un 20% en el último año.

CEO

Sarah London (42 yo)

2.1yrs

Tenure

US$18,556,966

Compensation

Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sarah London	CEO & Director	2.1yrs	US$18.56m	0.018% $ 115.3m
Kenneth Fasola	President	1.3yrs	US$10.62m	0.010% $ 66.2m
Andrew Asher	Executive VP & CFO	2.9yrs	US$9.91m	0.036% $ 230.6m
Christopher Koster	Executive VP	4.2yrs	US$4.84m	0.017% $ 111.1m
David Thomas	CEO of Markets & Medicaid	5.3yrs	US$6.20m	0.0089% $ 56.8m
Susan Smith	Chief Operating Officer	less than a year	no data	no data
Katie Casso	Senior VP	3yrs	no data	0.0051% $ 32.6m
Brian LeClaire	Chief Information Officer	1.3yrs	no data	no data
Jennifer Gilligan	Senior Vice President of Investor Relations	4yrs	no data	no data
Ashlee Knuckey	Chief Risk	1.6yrs	no data	no data
Shannon Susko	Senior VP & Chief Communications Officer	less than a year	no data	no data
Suzy DePrizio	Senior VP & Chief Marketing Officer	2.9yrs	no data	no data

2.5yrs

Average Tenure

55.5yo

Average Age

Equipo directivo experimentado: CNC *El equipo directivo de la empresa se considera experimentado (2.6 años de antigüedad media).

Board Members

Name	Position	Tenure	Compensation	Ownership
Sarah London	CEO & Director	2.6yrs	US$18.56m	0.018% $ 115.3m
Monte Ford	Independent Director	1.4yrs	US$324.98k	0.00026% $ 1.7m
Frederick Eppinger	Independent Chairman	18yrs	US$537.45k	0.00030% $ 1.9m
Christopher Coughlin	Independent Director	2.3yrs	US$369.98k	0.0028% $ 18.0m
H. Dallas	Lead Independent Director	4.3yrs	US$474.98k	0.0042% $ 26.7m
Wayne DeVeydt	Independent Director	2.3yrs	US$372.48k	0.00052% $ 3.3m
Theodore Samuels	Independent Director	2.3yrs	US$349.98k	0.0039% $ 25.2m
Kenneth Burdick	Director	2.3yrs	US$1.25m	0.082% $ 523.1m
Jessica Blume	Independent Director	6.2yrs	US$344.98k	0.0035% $ 22.7m
Lori Robinson	Independent Director	4.5yrs	US$299.98k	0.0016% $ 10.2m

2.4yrs

Average Tenure

64yo

Average Age

Junta con experiencia: CNC *no se consideran experimentados ( 2.1 años de permanencia media), lo que sugiere un nuevo consejo.

Centene Management

Management criteria checks 1/4

Key information

Recent management updates

Centene Corporation, Annual General Meeting, May 14, 2024

President recently sold Mex$15m worth of stock

High number of new directors

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

High number of new directors

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Recent updates

Centene Corporation, Annual General Meeting, May 14, 2024

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings released: EPS: US$4.97 (vs US$2.09 in FY 2022)

President recently sold Mex$15m worth of stock

Full year 2023 earnings released: EPS: US$4.97 (vs US$2.09 in FY 2022)

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

High number of new directors

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

High number of new directors

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$0.87 (vs US$1.29 in 3Q 2022)

Centene Corporation Names Wade Rakes as Chief Growth Officer

High number of new directors

Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023

High number of new directors

High number of new directors

Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion.

High number of new directors

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023

New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation.

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC).

Centene to Divest AI Platform Apixio

First quarter 2023 earnings released: EPS: US$2.05 (vs US$1.46 in 1Q 2022)

CEO & Director recently bought Mex$35m worth of stock

Independent Director recently bought Mex$9.5m worth of stock

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released: EPS: US$2.09 (vs US$2.31 in FY 2021)

Centene Corporation to Report Fiscal Year 2022 Results on Feb 07, 2023

Centene Corporation Announces Management Changes

Vivalto Santé SA completed the acquisition of Torrejon Salud, S.A. from Centene Corporation (NYSE:CNC).

Vivalto Santé SA completed the acquisition of Ribera Salud, S.A from Centene Corporation (NYSE:CNC).

Centene Corporation Appoints Monte Ford to Board of Directors

High number of new directors

Third quarter 2022 earnings released: EPS: US$1.29 (vs US$1.00 in 3Q 2021)

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation to Report Q3, 2022 Results on Oct 25, 2022

High number of new directors

Centene Corporation Appoints Ashlee Knuckey as Chief Ethics and Compliance Officer

High number of new directors

Centene Corporation Announces James Dallas to Step Down as Chairman of the Board

Vivalto Sante Investissement entered into agreement to acquire Ribera Salud, S.A from Centene Corporation (NYSE:CNC) on July 25, 2022.

Vivalto Santé SA agreed to acquire SPANISH AND CENTRAL EUROPEAN BUSINESSES Of CENTENE from Centene Corporation (NYSE:CNC).

High number of new directors

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC completed the acquisition of PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Q2, 2022 Results on Jul 26, 2022

Centene Corporation Revises Revenue Guidance for the Fiscal Year 2022

High number of new directors

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC signed a definitive agreement to acquire PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation Announces Resignation of Leslie V. Norwalk, Esq. as A Member of the Board

Centene Corporation Announces Executive Changes

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Reportedly Drew Takeover Interest from Cigna in Recent Months

Centene Corporation (NYSE:CNC) completed the acquisition of Magellan Health, Inc. (NasdaqGS:MGLN) from a group of shareholders.

Centene Corporation Reaffirms earnings Guidance for 2021; Provides Earnings Guidance for 2022

Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon completed the acquisition of an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC).

Third quarter 2021 earnings released: EPS US$1.00 (vs US$0.98 in 3Q 2020)

Independent Director David Steward has left the company

Executive Vice President of HealthCare Enterprises Jeffrey Schwaneke has left the company

Executive Vice President of HealthCare Enterprises Jeffrey Schwaneke has left the company

Second quarter 2021 earnings released: US$0.92 loss per share (vs US$2.08 profit in 2Q 2020)